Skip to main content

Table 1 Patient Demographics: Characteristics of pregnant patients exposed to OnabotulinumtoxinA

From: OnabotulinumtoxinA for chronic migraine during pregnancy: a real world experience on 45 patients

  All
(N = 45)
Continue onabotulinumtoxinA
(N = 32)
Stopped onabotulinumtoxinA
(N = 13)
Age 30.9 (19–42) 29.8 (19–36) 33.3 (21–42)
Migraine Onset 14.4 (8–23) 14.5 (8–23) 14.2 (8–23)
CM Duration 3.7 (0.5–10) 3.6 (0.5–10) 3.8 (1–8)